Hepatitis B virus molecular biology and pathogenesis

Abstract

As obligate intracellular parasites, viruses need a host cell to provide a milieu favorable to viral replication. Consequently, viruses often adopt mechanisms to subvert host cellular signaling processes. While beneficial for the viral replication cycle, virus-induced deregulation of host cellular signaling processes can be detrimental to host cell physiology and can lead to virus-associated pathogenesis, including, for oncogenic viruses, cell transformation and cancer progression. Included among these oncogenic viruses is the hepatitis B virus (HBV). Despite the availability of an HBV vaccine, 350-500 million people worldwide are chronically infected with HBV, and a significant number of these chronically infected individuals will develop hepatocellular carcinoma (HCC). Epidemiological studies indicate that chronic infection with HBV is the leading risk factor for the development of HCC. Globally, HCC is the second highest cause of cancer-associated deaths, underscoring the need for understanding mechanisms that regulate HBV replication and the development of HBV-associated HCC. HBV is the prototype member of the Hepadnaviridae family; members of this family of viruses have a narrow host range and predominately infect hepatocytes in their respective hosts. The extremely small and compact hepadnaviral genome, the unique arrangement of open reading frames, and a replication strategy utilizing reverse transcription of an RNA intermediate to generate the DNA genome are distinguishing features of the Hepadnaviridae. In this review, the authors provide a comprehensive description of HBV biology, summarize the model systems used for studying HBV infections, and highlight potential mechanisms that link a chronic HBV-infection to the development of HCC. For example, the HBV X protein (HBx), a key regulatory HBV protein that is important for HBV replication, is thought to play a cofactor role in the development of HBV-induced HCC, and the authors highlight the functions of HBx that may contribute to the development of HBV-associated HCC.

Keywords

Hepatitis B virus / hepatocellular carcinoma / hepatitis B virus life cycle / hepatitis B virus-associated disease

References

[1] Blumberg BS.Australia antigen and the biology of hepatitis B..Science1977;197:17-25

[2] Blumberg BS,Hungerford DA,Sutnick AI.A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis..Ann Intern Med1967;66:924-31

[3] Maccallum FO.Homologous serum hepatitis..Proc R Soc Med1946;39:655-7

[4] Alter HJ,Purcell RH,Feinstone SM,Schmidt PJ.Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors..Ann Intern Med1972;77:691-9

[5] Choo QL,Weiner AJ,Bradley DW.Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome..Science1989;244:359-62

[6] Blumberg BS,London WT,Hesser JE,Saimot G.The relation of infection with the hepatitis B agent to primary hepatic carcinoma..Am J Pathol1975;81:669-82

[7] Prince AM,Michon J,Diebolt G,Quenum C.A case/control study of the association between primary liver cancer and hepatitis B infection in Senegal..Int J Cancer1975;16:376-83

[8] Blumberg BS,inventor.Vaccine against viral hepatitis and process..United States patent US3636191 A. 1972 Jan 18

[9] Buynak EB,Tytell AA,Lampson GP.Vaccine against human hepatitis B..JAMA1976;235:2832-4

[10] Purcell RH.Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees..Am J Med Sci1975;270:395-9

[11] Seeger C,Mason WS.Hepadnaviruses..In: Knipe DM, Howley PM, editors. Field's Virology. 6th ed.2014;Philadelphia, PAWolters Kluwer/Lippincott Williams & Wilkins Health3376-436

[12] Scaglione SJ.Effectiveness of hep atitis B treatment in clinical practice..Gastroenterology2012;142:1360-8

[13] Suh A,Schmitz J.The genome of a Mesozoic paleovirus reveals the evolution of hepatitis B viruses..Nat Commun2013;4:1791

[14] Paraskevis D,Magiorkinis E,Belshaw R,Hatzakis A.Dating the origin and dispersal of hepatitis B virus infection in humans and primates..Hepatology2013;57:908-16

[15] Sureau C,Hubbard GB,Essex M.A molecularly cloned hepatitis B virus produced in vitro is infectious in a chimpanzee..J Virol1988;62:3064-7

[16] Yan RQ,Huang DR,Yang C.Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus..J Cancer Res Clin Oncol1996;122:283-8

[17] Locarnini S,Aziz MN.Possible origins and evolution of the hepatitis B virus (HBV)..Semin Cancer Biol2013;23:561-75

[18] Tatematsu K,Kurbanov F,Mano S,Nakayoshi T,Miyakawa Y.A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J..J Virol2009;83:10538-47 PMCID:PMC2753143

[19] Tran TT,Abe K.New complex recombinant genotype of hepatitis B virus identified in Vietnam..J Virol2008;82:5657-63 PMCID:PMC2395174

[20] Kurbanov F,Kramvis A,Mizokami M.When should "I" consider a new hepatitis B virus genotype?.J Virol2008;82:8241-2

[21] Chu CJ,Han SH,Min AD,Carey W,Luketic VA,Lok AS.Hepatitis B virus genotypes in the United States: results of a nationwide study..Gastroenterology2003;125:444-51

[22] Shi W,Ling C,Zhu C,Higgins DG.Hepatitis B virus subgenotyping: history, effects of recombination, misclassifications, and corrections..Infect Genet Evol2013;16:355-61

[23] Kao JH,Lai MY.Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B..Gastroenterology2000;118:554-9

[24] Seo Y.Short- and long-term outcome of interferon therapy for chronic hepatitis B infection..World J Gastroenterol2014;20:13284-92 PMCID:PMC4188886

[25] Chen HS,Girones R,Hornbuckle WE,Cote PJ,Purcell RH.The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks..J Virol1993;67:1218-26

[26] Keasler VV,Madden CR.Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo..J Virol2007;81:2656-62 PMCID:PMC1865975

[27] Zoulim F,Seeger C.Woodchuck hepatitis virus X protein is required for viral infection in vivo..J Virol1994;68:2026-30

[28] Lucifora J,Durantel D,Strubin M,Zoulim F,Protzer U.Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection..J Hepatol2011;55:996-1003

[29] Tsuge M,Akiyama R,Matsushita M,Abe H,Hatakeyama T,Miki D,Imamura M,Hayes CN.HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice..J Gen Virol2010;91:1854-64

[30] Nassal M.HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B..Gut2015;64:1972-84

[31] Seeger C.Molecular biology of hepatitis B virus infection..Virology2015;479-480C:672-86

[32] Doitsh G.Enhancer I predominance in hepatitis B virus gene expression..Mol Cell Biol2004;24:1799-808 PMCID:PMC344184

[33] Bar-Yishay I,Shlomai A.Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression..Liver Int2011;31:282-90

[34] Wang J,Ou JH.Proteolytic conversion of hepatitis B virus e antigen precursor to end product occurs in a postendoplasmic reticulum compartment..J Virol1991;65:5080-3

[35] Chen MT,Sällberg M,Chisari FV,Hughes J.A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen..Proc Natl Acad Sci U S A2004;101:14913-8 PMCID:PMC522042

[36] Chen M,Hughes J,Guidotti LG,Billaud JN.Immune tolerance split between hepatitis B virus precore and core proteins..J Virol2005;79:3016-27 PMCID:PMC548461

[37] Liaw YF.HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B..Hepatol Int2009;3:425-33 PMCID:PMC2748370

[38] Eble BE,Lingappa VR.Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen..Mol Cell Biol1987;7:3591-601 PMCID:PMC368013

[39] Peterson DL,Gavilanes F.Structure of hepatitis B surface antigen. Correlation of subtype with amino acid sequence and location of the carbohydrate moiety..J Biol Chem1982;257:10414-20

[40] Eble BE,Ganem D.The N-terminal (pre-S2) domain of a hepatitis B virus surface glycoprotein is translocated across membranes by downstream signal sequences..J Virol1990;64:1414-9

[41] Gripon P,Urban S.Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein..J Virol2005;79:1613-22 PMCID:PMC544121

[42] Yan H,Xu G,Jing Z,Huang Y,Peng B,Fu L,Chen P,Ren B,Cai T,Sui J.Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus..Elife2012;1:e00049

[43] Urban S,Kubitz R.Strategies to inhibit entry of HBV and HDV into hepatocytes..Gastroenterology2014;147:48-64

[44] Ganem D.Hepatitis B virus infection--natural history and clinical consequences..N Engl J Med2004;350:1118-29

[45] Bruss V.Envelopment of the hepatitis B virus nucleocapsid..Virus Res2004;106:199-209

[46] Bruns M,Chassot S.Enhancement of hepatitis B virus infection by noninfectious subviral particles..J Virol1998;72:1462-8

[47] Stannard LM.Morphological irregularities in Dane particle cores..J Gen Virol1979;45:509-14

[48] Birnbaum F.Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein..J Virol1990;64:3319-30

[49] Li HC,Su PY,Yang CC,Chang WC.Nuclear export and import of human hepatitis B virus capsid protein and particles..PLoS Pathog2010;6:e1001162

[50] Perlman DH,O'connor PB,Hu J.Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids..Proc Natl Acad Sci U S A2005;102:9020-5 PMCID:PMC1157036

[51] Ludgate L,Nguyen DH,Mentzer L.Cyclin-dependent kinase 2 phosphorylates s/t-p sites in the hepadnavirus core protein C-terminal domain and is incorporated into viral capsids..J Virol2012;86:12237-50 PMCID:PMC3486511

[52] Melegari M,Schneider RJ.Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression..J Virol2005;79:9810-20 PMCID:PMC1181610

[53] Bock CT,Locarnini S,Manns MP,Zentgraf H.Structural organization of the hepatitis B virus minichromosome..J Mol Biol2001;307:183-96

[54] Nassal M.The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly..J Virol1992;66:4107-16

[55] Le Pogam S,Newman M.Exposure of RNA templates and encapsidation of spliced viral RNA are influenced by the arginine-rich domain of human hepatitis B virus core antigen (HBcAg 165-173)..J Virol2005;79:1871-87 PMCID:PMC544126

[56] Chu TH,Su PY,Shih C.Nucleic acid chaperone activity associated with the arginine-rich domain of human hepatitis B virus core protein..J Virol2014;88:2530-43 PMCID:PMC3958103

[57] Lewellyn EB.The arginine clusters of the carboxy-terminal domain of the core protein of hepatitis B virus make pleiotropic contributions to genome replication..J Virol2011;85:1298-309 PMCID:PMC3020508

[58] Le Pogam S.Influence of a putative intermolecular interaction between core and the pre-S1 domain of the large envelope protein on hepatitis B virus secretion..J Virol2002;76:6510-7 PMCID:PMC136289

[59] Zlotnick A,Tan Z,Turner W.Core protein: a pleiotropic keystone in the HBV lifecycle..Antiviral Res2015;121:82-93 PMCID:PMC4537649

[60] Mason WS,Summers J.Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus..J Virol1980;36:829-36

[61] Summers J.Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate..Cell1982;29:403-15

[62] Bartenschlager R.The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription..EMBO J1988;7:4185-92

[63] Zoulim F.Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase..J Virol1994;68:6-13

[64] Weber M,Bartos H,Bartenschlager R.Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription..J Virol1994;68:2994-9

[65] Radziwill G,Schaller H.Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity..J Virol1990;64:613-20

[66] Kim S,Ryu WS.Four conserved cysteine residues of the hepatitis B virus polymerase are critical for RNA pregenome encapsidation..J Virol2009;83:8032-40 PMCID:PMC2715788

[67] Xiong Y.Origin and evolution of retroelements based upon their reverse transcriptase sequences..EMBO J1990;9:3353-62

[68] Nassal M.Hepatitis B viruses: reverse transcription a different way..Virus Res2008;134:235-49

[69] Wang YX,Zhao D,Nassal M.Extensive mutagenesis of the conserved box E motif in duck hepatitis B virus P protein reveals multiple functions in replication and a common structure with the primer grip in HIV-1 reverse transcriptase..J Virol2012;86:6394-407 PMCID:PMC3393573

[70] Tavis JE,Hu Y,Cao F,Aurora R,Jacobsen EJ,Sarafianos SG.The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes..PLoS Pathog2013;9:e1003125

[71] Bartenschlager R,Schaller H.The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation..J Virol1990;64:5324-32

[72] Jones SA.Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention..Emerg Microbes Infect2013;2:e56

[73] Belloni L,De Nicola F,Raffa G,Raimondo G.Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function..Proc Natl Acad Sci U S A2009;106:19975-9 PMCID:PMC2775998

[74] Seeger C.Targeting hepatitis B virus with CRISPR/Cas9..Mol Ther Nucleic Acids2014;3:e216

[75] Zhang Z,Hu Z,Liang TJ.X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo..J Clin Invest2001;108:1523-31 PMCID:PMC209423

[76] Xu Z,Wu L,Tan W,Ou JH.Enhancement of hepatitis B virus replication by its X protein in transgenic mice..J Virol2002;76:2579-84 PMCID:PMC153824

[77] Tsuge M,Takaishi H,Oga H,Takahashi S,Fujimoto Y,Chayama K,Yoshizato K.Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus..Hepatology2005;42:1046-54

[78] Bouchard MJ.The enigmatic X gene of hepatitis B virus..J Virol2004;78:12725-34 PMCID:PMC524990

[79] Bouchard MJ,Schneider RJ.Calcium signaling by HBx protein in hepatitis B virus DNA replication..Science2001;294:2376-8

[80] Melegari M,Wands JR.Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective..Hepatology1998;27:628-33

[81] Tang H,Huang F,Liu L,Zhao L.The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication..J Virol2005;79:5548-56 PMCID:PMC1082733

[82] Leupin O,Schaeffer C.Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death..J Virol2005;79:4238-45 PMCID:PMC1061538

[83] Clippinger AJ,Bouchard MJ.Hepatitis B virus X protein modulates apoptosis in primary rat hepatocytes by regulating both NF-kappaB and the mitochondrial permeability transition pore..J Virol2009;83:4718-31 PMCID:PMC2682098

[84] Gearhart TL.Replication of the hepatitis B virus requires a calcium-dependent HBx-induced G1 phase arrest of hepatocytes..Virology2010;407:14-25 PMCID:PMC2946470

[85] Gearhart TL.The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication..J Virol2010;84:2675-86 PMCID:PMC2826060

[86] Rawat S.The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival..J Virol2015;89:999-1012 PMCID:PMC4300660

[87] Slagle BL,Bouchard MJ,Ou JH.Technical standards for hepatitis B virus X protein (HBx) research..Hepatology2015;61:1416-24 PMCID:PMC4320676

[88] Keng VW,Bell JB.Modeling hepatitis B virus X-induced hepatocellular carcinoma in mice with the sleeping beauty transposon system..Hepatology2011;53:781-90 PMCID:PMC3079950

[89] Kim CM,Saito I,Jay G.HBx gene of hepatitis B virus induces liver cancer in transgenic mice..Nature1991;351:317-20

[90] Koike K.Hepatitis B virus X gene is implicated in liver carcinogenesis..Cancer Lett2009;286:60-8

[91] Madden CR,Slagle BL.Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions..J Virol2001;75:3851-8 PMCID:PMC114876

[92] Bouchard MJ.Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges..Cancer Lett2011;305:123-43 PMCID:PMC3071446

[93] Arbuthnot P,Kew M.Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways..J Gastroenterol Hepatol2000;15:357-68

[94] Tanaka Y,Ichimura T,Asaoka Y,Jazag A,Imamura J,Ijichi H,Isobe T.The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1..Oncogene2006;25:633-42

[95] Kim JH.Activation of the human transforming growth factor alpha (TGF-alpha) gene by the hepatitis B viral X protein (HBx) through AP-2 sites..Mol Cell Biochem2002;231:155-61

[96] Lara-Pezzi E,Majano PL,López-Cabrera M.The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway..EMBO J1998;17:7066-77 PMCID:PMC1171054

[97] Lucito R.Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C..J Virol1992;66:983-91

[98] Um HR,Chae SY,Park JH.Raf-1 and protein kinase B regulate cell survival through the activation of NF-kappaB in hepatitis B virus X-expressing cells..Virus Res2007;125:1-8

[99] Yun C,Jin YH,Lee MO,Lee JH.NF-kappaB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival..Cancer Lett2002;184:97-104

[100] Hsieh A,Lim SO,Jung G.Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling..Cancer Lett2011;300:162-72

[101] Iyer S.Interaction of mutant hepatitis B X protein with p53 tumor suppressor protein affects both transcription and cell survival..Mol Carcinog2011;50:972-80 PMCID:PMC3125428

[102] Chung TW,Kim CH.Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential..FASEB J2004;18:1123-5

[103] Yan H,He W,Qi Y,Gao Z,Song M,Sui J.Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide..J Virol2013;87:7977-91 PMCID:PMC3700185

[104] Blanchet M.Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues..J Virol2007;81:5841-9 PMCID:PMC1900317

[105] Gripon P,Rumin S.Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity..Virology1995;213:292-9

[106] Schulze A,Urban S.Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans..Hepatology2007;46:1759-68

[107] Verrier ER,Bach C,Weiss A,Durand SC,Durantel D,López Ledesma MM,Soumillon M,Pochet N,Schuster C,Sureau C.A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses..Hepatology2016;63:35-48

[108] Huang HC,Chang WC,Huang C.Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis..J Virol2012;86:9443-53 PMCID:PMC3416113

[109] Rabe B,Bischof A,Sominskaya I,Cazenave C,Kann M.Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids..PLoS Pathog2009;5:e1000563

[110] Schmitz A,Foss M,Rabe B,Stoeber M,Kann M.Nucleoporin 153 arrests the nuclear import of hepatitis B virus capsids in the nuclear basket..PLoS Pathog2010;6:e1000741

[111] Guidotti LG,Loh YT,Chisari FV.Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice..J Virol1994;68:5469-75

[112] Guidotti LG,Schaller H.High-level hepatitis B virus replication in transgenic mice..J Virol1995;69:6158-69

[113] Fourel I,Schaffer P.The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver..J Virol1994;68:1059-65

[114] Luo L,Gong Q,Lei Y,He S.Hepatitis B virus X protein modulates remodelling of minichromosomes related to hepatitis B virus replication in HepG2 cells..Int J Mol Med2013;31:197-204

[115] Rivière L,Ducroux A,Deng Q,Buendia MA,Neuveut C.HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase..J Hepatol2015;63:1093-102

[116] Jeong JK,Ryu WS.Evidence that the 5'-end cap structure is essential for encapsidation of hepatitis B virus pregenomic RNA..J Virol2000;74:5502-8 PMCID:PMC112035

[117] Lee HJ,Shin MK.Polyadenylation is dispensable for encapsidation and reverse transcription of hepatitis B viral pregenomic RNA..Mol Cells2008;25:545-52

[118] Kim S,Ryu WS.Incorporation of eukaryotic translation initiation factor eIF4E into viral nucleocapsids via interaction with hepatitis B virus polymerase..J Virol2010;84:52-8 PMCID:PMC2798451

[119] Hu J,Seeger C.Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids..EMBO J1997;16:59-68 PMCID:PMC1169614

[120] Nassal M.A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis..J Virol1996;70:2764-73

[121] Loeb DD,Ganem D.Sequence-independent RNA cleavages generate the primers for plus strand DNA synthesis in hepatitis B viruses: implications for other reverse transcribing elements..EMBO J1991;10:3533-40

[122] Staprans S,Ganem D.Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA..J Virol1991;65:1255-62

[123] Bill CA.Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration..Proc Natl Acad Sci U S A2004;101:11135-40 PMCID:PMC503752

[124] Maguire ML.cis-Acting sequences that contribute to synthesis of minus-strand DNA are not conserved between hepadnaviruses..J Virol2010;84:12824-31 PMCID:PMC3004326

[125] Lewellyn EB.Base pairing between cis-acting sequences contributes to template switching during plus-strand DNA synthesis in human hepatitis B virus..J Virol2007;81:6207-15 PMCID:PMC1900078

[126] Tan Z,Unchwaniwala N,Loeb DD.The interface between hepatitis B virus capsid proteins affects self-assembly, pregenomic RNA packaging, and reverse transcription..J Virol2015;89:3275-84 PMCID:PMC4337549

[127] Tuttleman JS,Summers J.Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells..Cell1986;47:451-60

[128] Wu TT,Aldrich CE,Mason WS.In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway..Virology1990;175:255-61

[129] Summers J,Horwich AL.Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification..J Virol1990;64:2819-24

[130] Lentz TB.Roles of the envelope proteins in the amplification of covalently closed circular DNA and completion of synthesis of the plus-strand DNA in hepatitis B virus..J Virol2011;85:11916-27 PMCID:PMC3209309

[131] Zhang YY,Theele D,Toll E.Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver..Proc Natl Acad Sci U S A2003;100:12372-7 PMCID:PMC218765

[132] Laras A,Dimou E,Hadziyannis SJ.Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients..Hepatology2006;44:694-702

[133] Mason WS,Xu C.Hepatocyte turnover in transient and chronic hepadnavirus infections..J Viral Hepat2007;14:22-8

[134] Addison WR,Wong WW,Madej D,Tyrrell DL.Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication..J Virol2002;76:6356-63 PMCID:PMC136192

[135] Ning X,Mentzer L,Lee H,Hafenstein S.Secretion of genome-free hepatitis B virus--single strand blocking model for virion morphogenesis of para-retrovirus..PLoS Pathog2011;7:e1002255

[136] Gerelsaikhan T,Bruss V.Hepatitis B virus nucleocapsid envelopment does not occur without genomic DNA synthesis..J Virol1996;70:4269-74

[137] Yuan TT,Whitehead WE,Shih C.The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen..J Virol1999;73:5731-40

[138] Nowak MA,Hill AM,Thomas HC.Viral dynamics in hepatitis B virus infection..Proc Natl Acad Sci U S A1996;93:4398-402 PMCID:PMC39549

[139] Watanabe T,Naito A,Kim S.Involvement of host cellular multivesicular body functions in hepatitis B virus budding..Proc Natl Acad Sci U S A2007;104:10205-10 PMCID:PMC1891263

[140] Bruss V.Hepatitis B virus morphogenesis..World J Gastroenterol2007;13:65-73 PMCID:PMC4065877

[141] Summers J,Snyder R.A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks..Proc Natl Acad Sci U S A1978;75:4533-7 PMCID:PMC336150

[142] Lenhoff RJ,Summers J.Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus..Hepatology1999;29:563-71

[143] Newbold JE,Tencza M,Dean J,Locarnini S.The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes..J Virol1995;69:3350-7

[144] Guo JT,Liu C,Saputelli J,Barrasa MI,Seeger C.Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections..J Virol2000;74:1495-505 PMCID:PMC111485

[145] Kajino K,Saputelli J,Cullen J.Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte..J Virol1994;68:5792-803

[146] Vickery K.DHBV manipulation and prediction of the outcome of infection..J Virol1996;25:504-9

[147] Cote PJ,Bellezza C,Roneker C,Baldwin BH,Nakamura I,Tennant BC.Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infection..Hepatology2000;32:807-17

[148] Snyder RL,Summers J.Chronic hepatitis and hepatocellular carcinoma associated with woodchuck hepatitis virus..Am J Pathol1982;107:422-5

[149] Marion PL,Ho BK,Robinson WS.Liver disease associated with duck hepatitis B virus infection of domestic ducks..Proc Natl Acad Sci U S A1984;81:898-902 PMCID:PMC344946

[150] Kock J,MacNelly S,Blum HE.Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus..J Virol2001;75:5084-9 PMCID:PMC114913

[151] Tsukiyama-Kohara K.Tupaia belangeri as an experimental animal model for viral infection..Exp Anim2014;63:367-74 PMCID:PMC4244285

[152] Yang EB,Su JJ.The tree shrews: useful animal models for the viral hepatitis and hepatocellular carcinoma..Hepatogastroenterology2005;52:613-6

[153] Zhao X,Wolff-Vorbeck G,Levy S,Blum HE.Primary hepatocytes of tupaia belangeri as a potential model for hepatitis C virus infection..J Clin Invest2002;109:221-32 PMCID:PMC150834

[154] Li Y,Wei W,Cao J,Ou C,Yang C.Candidate genes responsible for human hepatocellular carcinoma identified from differentially expressed genes in hepatocarcinogenesis of the tree shrew (tupaia belangeri chinesis)..Hepatol Res2008;38:85-95

[155] Meier A,Weiss TS,Urban S.Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes..Hepatology2013;58:31-42

[156] Yang C,Ou C,Cao J,Tang Y,Qin H,Li Y.Chronic hepatitis B virus infection and occurrence of hepatocellular carcinoma in tree shrews (tupaia belangeri chinensis)..Virol J2015;12:26 PMCID:PMC4369070

[157] Cheng L,Bility MT,Su L.Modeling hepatitis B virus infection, immunopathology and therapy in mice..Antiviral Res2015;121:1-8 PMCID:PMC4536188

[158] Barker LF,McGrath PP,Kirschstein RL,Edington TS,Peterson MR.Transmission of type B viral hepatitis to chimpanzees..J Infect Dis1973;127:648-62

[159] Shouval D,Ruiz-Opazo N,Spigland I,Gerber MA,Popper H.Chronic hepatitis in chimpanzee carriers of hepatitis B virus: morphologic, immunologic, and viral DNA studies..Proc Natl Acad Sci U S A1980;77:6147-51 PMCID:PMC350231

[160] Wieland S,Purcell RH.Genomic analysis of the host response to hepatitis B virus infection..Proc Natl Acad Sci U S A2004;101:6669-74 PMCID:PMC404103

[161] Thimme R,Steiger C,Reimann KA,Chisari FV.CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection..J Virol2003;77:68-76 PMCID:PMC140637

[162] Wieland SF,Engle RE,Chisari FV.Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver..J Virol2014;88:5184-8 PMCID:PMC3993806

[163] Asabe S,Chattopadhyay PK,Engle RE,Chisari FV.The size of the viral inoculum contributes to the outcome of hepatitis B virus infection..J Virol2009;83:9652-62 PMCID:PMC2748002

[164] Murray JM,Wieland SF.The half-life of hepatitis B virions..Hepatology2006;44:1117-21

[165] Guidotti LG,Hobbs MV,Schreiber R.Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes..Immunity1996;4:25-36

[166] Heise T,Cavanaugh VJ.Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice..J Virol1999;73:474-81

[167] Lanford RE,Chavez D,Hodara VL,Fosdick A,Zheng J,Halcomb RL.GS-9620, an oral agonist of toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees..Gastroenterology2013;144:1508-17 PMCID:PMC3691056

[168] Kamili S,Thompson G,Walker CM,Krawczynski K.Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model..Hepatology2009;49:1483-91

[169] Payette PJ,Weeratna RD,Shapiro M,Davis HL.Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge..Intervirology2006;49:144-51

[170] Prince AM,Purcell RH.A final report on safety and immunogenicity of a bivalent aqueous subunit HBV vaccine..J Med Virol1985;15:399-419

[171] Wadman M.Animal rights: chimpanzee research on trial..Nat2011;474:268-71

[172] Dandri M.Mouse models of hepatitis B and delta virus infection..J Immunol Methods2014;410:39-49

[173] Na B,Wang Q,Tian Y,Yu J,Kakar S,Ou JH,Yen TS.Transgenic expression of entire hepatitis B virus in mice induces hepatocarcinogenesis independent of chronic liver injury..PloS One2011;6:e26240

[174] Lütgehetmann M,Volz T,Allweiss L,Pollok JM,Petersen J,Dandri M.Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation..Hepatology2012;55:685-94

[175] Bility MT,Zhang Z,Li F,Zhang L,Gao Y,Niu J,Su L.Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages..PLoS Pathog2014;10:e1004032

[176] Giersch K,Volz T,Bierwolf J,Pollok JM,Dandri M.Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection..J Hepatol2015;63:346-53

[177] Volz T,Ben MBarek M,Lohse AW,Alexandrov A,Petersen J,Dandri M.The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus..J Hepatol2013;58:861-7

[178] Brezillon N,Massinet H,Lamant C,Berissi S,Hannoun L,Wimmer E,Hantz O,Morosan S.Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice..PloS One2011;6:e25096

[179] Redelsperger F,Mandouri Y,Duriez M,Roque Afonso AM,Dubreuil P,Perlemuter G,Bacon N,Zatla F,Pol S,Di Santo J,Soussan P.Production of hepatitis B defective particles is dependent on liver status..Virology2012;431:21-8

[180] Oehler N,Bhadra OD,Allweiss L,Bierwolf J,Pollok JM,Fehse B,Urban S,Heeren J.Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism..Hepatology2014;60:1483-93

[181] Belloni L,Guerrieri F,Volz T,Petersen J,Dandri M.IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome..J Clin Invest2012;122:529-37 PMCID:PMC3266786

[182] Ni Y,Mehrle S,Kaufman C,Stindt J,Nassal M,Sültmann H.Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes..Gastroenterology2014;146:1070-83

[183] Li H,Wang Y,Zhao J,Zhang J,Yuan Q,Han J.HBV life cycle is restricted in mouse hepatocytes expressing human NTCP..Cell Mol Immunol2014;11:175-83 PMCID:PMC4003384

[184] He W,Mao F,Li Y,Peng B,Qi Y,Guo JT,Wang F.Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide..PLoS Pathog2015;11:e1004840

[185] Gearhart TL.The hepatitis B virus HBx protein modulates cell cycle regulatory proteins in cultured primary human hepatocytes..Virus Res2011;155:363-7 PMCID:PMC3010534

[186] Lamontagne J,Bouchard MJ.Transcriptome-wide analysis of hepatitis B virus-mediated changes to normal hepatocyte gene expression..PLoS Pathog2016;12:e1005438

[187] Alexander JJ,Geddes EW.Establishment of a continuously growing cell line from primary carcinoma of the liver..S Afr Med J1976;50:2124-8

[188] Knowles BB,Aden DP.Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen..Science1980;209:497-9

[189] Aden DP,Plotkin S,Knowles BB.Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line..Nature1979;282:615-6

[190] Shaul Y,Garcia PD,Hsu H,Rutter WJ.Cloning and analysis of integrated hepatitis virus sequences from a human hepatoma cell line..J Virol1984;51:776-87

[191] Edman JC,Valenzuela P,Rutter WJ.Integration of hepatitis B virus sequences and their expression in a human hepatoma cell..Nature1980;286:535-8

[192] Twist EM,Aden DP,Plotkin SA.Integration pattern of hepatitis B virus DNA sequences in human hepatoma cell lines..J Virol1981;37:239-43

[193] Nakabayashi H,Miyano K,Sato J.Growth of human hepatoma cells lines with differentiated functions in chemically defined medium..Cancer Res1982;42:3858-63

[194] Chang CM,Hu CP,Su TS,Chou CK,Pfaff E.Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line..EMBO J1987;6:675-80

[195] Yaginuma K,Kobayashi M.Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA..Proc Natl Acad Sci U S A1987;84:2678-82 PMCID:PMC304721

[196] Sells MA,Acs G.Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA..Proc Natl Acad Sci U S A1987;84:1005-9 PMCID:PMC304350

[197] Ladner SK,Barker CS,Wang GH,Seeger C.Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication..Antimicrob Agents Chemother1997;41:1715-20

[198] Chen JL,Liu K,Li Y,Bai L.New insights into Hepatitis B virus biology and implications for novel antiviral strategies..Natl Sci Rev2015;2:296-313

[199] Jiang Y,Shao LH,Yao YY,Chen FZ,Li Y.A new cell culture system for infection with hepatitis B virus that fuses HepG2 cells with primary human hepatocytes..J Int Med Res2009;37:650-61

[200] Sai LT,Guan YY,Ma RP.Hepatitis B virus infection and replication in a new cell culture system established by fusing HepG2 cells with primary human hepatocytes..J Microbiol Immunol Infect2014;

[201] Gripon P,Urban S,Glaise D,Guyomard C,Trepo C.Infection of a human hepatoma cell line by hepatitis B virus..Proc Natl Acad Sci U S A2002;99:15655-60 PMCID:PMC137772

[202] Yan R,Cai D,Cuconati A.Spinoculation enhances HBV infection in NTCP-reconstituted hepatocytes..PloS One2015;10:e0129889

[203] Zeisel MB,Mason WS,Beck J,Kann M,Benkirane M,Michel ML,Cosset FL,Trépo C,Carrat F,Schinazi RF,Delfraissy JF.Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure..Gut2015;64:1314-26

[204] Nkongolo S,Lempp FA,Lindner T,Lohmann V,Mehrle S.Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor..J Hepatol2014;60:723-31

[205] Yan H,Sui J.NTCP opens the door for hepatitis B virus infection..Antiviral Res2015;121:24-30

[206] Shlomai A,Ramanan V,de Jong YP,Rice CM.Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems..Proc Natl Acad Sci U S A2014;111:12193-8 PMCID:PMC4143014

[207] Neuveut C,Buendia MA.Mechanisms of HBV-related hepatocarcinogenesis..J Hepatol2010;52:594-604

[208] Clippinger AJ.Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential..J Virol2008;82:6798-811 PMCID:PMC2446973

[209] Chen CJ.Natural history of chronic hepatitis B revealed..J Gastroenterol Hepatol2011;26:628-38

[210] Guy CS,Churchill ND.Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus..J Virol2008;82:8579-91 PMCID:PMC2519695

[211] Wieland SF,Thimme R,Chisari FV.Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees..Proc Natl Acad Sci U S A2004;101:2129-34 PMCID:PMC357063

[212] Summers J.Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy..Proc Natl Acad Sci U S A2004;101:638-40 PMCID:PMC327200

[213] Schultz U,Staeheli P.Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha-treated hepatocytes..J Virol1999;73:5459-65

[214] Guo JT,Wang X,Hu J.Conditional replication of duck hepatitis B virus in hepatoma cells..J Virol2003;77:1885-93 PMCID:PMC140889

[215] Yim HJ.Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005..Hepatology2006;43:S173-81

[216] Blackberg J.Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation..J Hepatol2000;33:992-7

[217] Chazouillères O,Kim M,Ferrell L,Ascher NL."Occult" hepatitis B virus as source of infection in liver transplant recipients..Lancet1994;343:142-6

[218] Pollicino T,Cerenzia G,Raffa G,Farinati F,Smedile A,Villa E.Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection..Gastroenterology2004;126:102-10

[219] Gish RG,Lai CL,Lau JY,Schluep T.Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities..Antiviral Res2015;121:47-58

[220] Chang ML.Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management..J Hepatol2014;61:1407-17

[221] Liaw YF,Chu CM.The development of cirrhosis in patients with chronic type B hepatitis: a prospective study..Hepatology1988;8:493-6

[222] Globocan 2012 v1.0 [Internet]. IARC CancerBase No. 11. 2013. Available from: http://globocan.iarc.fr

[223] El-Serag HB.Epidemiology of viral hepatitis and hepatocellular carcinoma..Gastroenterology2012;142:1264-73 PMCID:PMC3338949

[224] El-Serag HB.Hepatocellular carcinoma: epidemiology and molecular carcinogenesis..Gastroenterology2007;132:2557-76

[225] Block TM,Fimmel CJ.Molecular viral oncology of hepatocellular carcinoma..Oncogene2003;22:5093-107

[226] McClune AC.Chronic hepatitis B and hepatocellular carcinoma..Clin Liver Dis2010;14:461-76

[227] Bagga S.Cell cycle regulation during viral infection..Methods Mol Biol2014;1170:165-227

[228] Casciano JC,Yang B.Modulation of cell proliferation pathways by the hepatitis B virus X protein: a potential contributor to the development of hepatocellular carcinoma.In: Lau WY, editor. Hepatocellular carcinoma - basic research. Shanghai, China: InTech;2011;103-53

[229] Rawat S,Bouchard MJ.Modulation of apoptotic signaling by the hepatitis B virus X protein..Viruses2012;4:2945-72 PMCID:PMC3509679

[230] Lamontagne J,Bouchard MJ.Hepatitis B virus and microRNAs: complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases..World J Gastroenterol2015;21:7375-99 PMCID:PMC4481434

[231] Panteva M,Jameel S.Hepatitis viruses and the MAPK pathway: is this a survival strategy?.Virus Res2003;92:131-40

[232] Wang Z,Jin H.mTOR in viral hepatitis and hepatocellular carcinoma: function and treatment..Biomed Res Int2014;2014:735672

[233] Guo H,Jiang D,Xiao GH,Guo JT.Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway..J Virol2007;81:10072-80 PMCID:PMC2045390

[234] Friedrich B,Brandenburg B,Will H.Induction of anti-proliferative mechanisms in hepatitis B virus producing cells..J Hepatol2005;43:696-703

[235] Wang CM,Fan CG,Sun WS,Jia JH.miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma..Biochem Biophys Res Commun2011;411:586-92

[236] Chin R,Koeberlein B,Zentgraf H,Gowans E,Torresi J.Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesis..J Hepatol2007;47:325-37

[237] Huang YQ,Yan SN.Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells..Hepatobiliary Pancreat Dis Int2004;3:543-7

[238] Ozer A,Mearns M,Genta RM,Yoffe B.Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication..Gastroenterology1996;110:1519-28

[239] Qiao L,McKinstry R,Yacoub A,Grant S,Fisher PB.Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression..Hepatology2001;34:906-17

[240] Shlomai A.The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon..Med Hypotheses2008;71:53-7

[241] Popescu CI,Vlaicu O,Rouille Y.Hepatitis C virus life cycle and lipid metabolism..Biology (Basel)2014;3:892-921

[242] Yan H,Liu Y,He W,Jing Z,Li W.Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide..J Virol2014;88:3273-84 PMCID:PMC3957944

[243] Reese VC,McLachlan A.Limited effects of bile acids and small heterodimer partner on hepatitis B virus biosynthesis in vivo..J Virol2012;86:2760-8 PMCID:PMC3302260

[244] Waris G.Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function..J Virol2002;76:2721-9 PMCID:PMC135980

[245] Li L,Kaestner KH.Limited effects of fasting on hepatitis B virus (HBV) biosynthesis in HBV transgenic mice..J Virol2009;83:1682-8 PMCID:PMC2643774

[246] Ondracek CR,Rushing CN,McLachlan A.Distinct regulation of hepatitis B virus biosynthesis by peroxisome proliferator-activated receptor gamma coactivator 1alpha and small heterodimer partner in human hepatoma cell lines..J Virol2009;83:12545-51 PMCID:PMC2786761

[247] Reese V,Rushing C,Oropeza CE.Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development..Int J Biochem Cell Biol2011;43:230-7 PMCID:PMC3773232

[248] Curtil C,Radreau P,Scholtès C,Roche D,Andre P.The metabolic sensors FXRα, PGC-1α, and SIRT1 cooperatively regulate hepatitis B virus transcription..FASEB J2014;28:1454-63

[249] Reese VC,McLachlan A.Independent activation of hepatitis B virus biosynthesis by retinoids, peroxisome proliferators, and bile acids..J Virol2013;87:991-7 PMCID:PMC3554059

[250] Ramière C,Diaz O,Perrin-Cocon L,Lotteau V.Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha..J Virol2008;82:10832-40 PMCID:PMC2573182

[251] Kim HY,Choi YH,Cheong J.Bile acids increase hepatitis B virus gene expression and inhibit interferon-alpha activity..FEBS J2010;277:2791-802

[252] Shlomai A,Shaul Y.PGC-1alpha controls hepatitis B virus through nutritional signals..Proc Natl Acad Sci U S A2006;103:16003-8 PMCID:PMC1635117

[253] Shin HJ,Kim SU,Park do S,Lee CH,Song IS,Kim M,Kim DG,Kim SK,Kim SS,Kim YB.Hepatitis B virus X protein regulates hepatic glucose homeostasis via activation of inducible nitric oxide synthase..J Biol Chem2011;286:29872-81 PMCID:PMC3191028

[254] Jagya N,Thakral D,Durgapal H.RNA-seq based transcriptome analysis of hepatitis E virus (HEV) and hepatitis B virus (HBV) replicon transfected Huh-7 cells..PLoS One2014;9:e87835

[255] Jhuang HJ,Lin KT,Wang FS,Lee KH,Lai JM,Huang CY.Gluconeogenesis, lipogenesis, and HBV replication are commonly regulated by PGC-1α-dependent pathway..Oncotarget2015;6:7788-803 PMCID:PMC4480716

[256] Benn J.Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade..Proc Natl Acad Sci U S A1994;91:10350-4 PMCID:PMC45017

[257] Doria M,Lucito R.The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors..EMBO J1995;14:4747-57

[258] Gehart H,Ittner A.MAPK signalling in cellular metabolism: stress or wellness?.EMBO Rep2010;11:834-40

[259] Luber B,Weiss L,Hofschneider PH.The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C..Res Virol1993;144:311-21

[260] Zhu M,Li W,Fu S,Xia H,Chen Y,Zheng S,Li M.Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells..Oncotarget2015;6:12196-208 PMCID:PMC4494932

[261] Teng CF,Wu HC,Tsai HW,Su IJ.Hepatitis B virus Pre-S2 mutant induces aerobic glycolysis through mammalian target of rapamycin signal cascade..PLoS One2015;10:e0122373

[262] Teng CF,Hsieh WC,Su IJ.Activation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis..J Virol2015;89:605-14 PMCID:PMC4301163

[263] Teng CF,Tsai HW,Huang W.Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy..Hepatology2011;54:1199-207

[264] Wang CC,Kao JH.Hepatitis B virus infection and metabolic syndrome: fact or fiction?.J Gastroenterol Hepatol2015;30:14-20

[265] Diao J,Sarangi F,Iorio C,Woodgett JR,Richardson CD.X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway..J Biol Chem2001;276:8328-40

[266] Elmore LW,Chang SF,Chang S,Geller DA,Harris CC.Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis..Proc Natl Acad Sci U S A1997;94:14707-12 PMCID:PMC25100

[267] Gottlob K,Levrero M.The hepatitis B virus HBx protein inhibits caspase 3 activity..J Biol Chem1998;273:33347-53

[268] Lee YI,Do SI.The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade..J Biol Chem2001;276:16969-77

[269] Pan J,Sun BS.Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B..J Gen Virol2001;82:171-82

[270] Klein A,Tzeng YJ,Levrero M,Graessmann A.HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53..Oncogene2003;22:2910-9

[271] Madden CR,Slagle BL.Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice..J Virol2000;74:5266-72 PMCID:PMC110881

[272] Bergametti F,Luber B,Tiollais P,Transy C.The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines..Oncogene1999;18:2860-71

[273] Chirillo P,Natoli G,Burgio VL,Levrero M.The hepatitis B virus X gene induces p53-mediated programmed cell death..Proc Natl Acad Sci U S A1997;94:8162-7 PMCID:PMC21574

[274] Kim H,Yun Y.X-gene product of hepatitis B virus induces apoptosis in liver cells..J Biol Chem1998;273:381-5

[275] Su F,Schneider RJ.Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein..J Virol2001;75:215-25 PMCID:PMC113915

[276] Terradillos O,Pollicino T,Sitterlin D,Gougeon ML,Buendia MA.The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver..Oncogene2002;21:377-86

[277] Lee YI,Im JH,Kim NS,Yu DY,Park SK.Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells..J Biol Chem2004;279:15460-71

[278] Su F.Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha..Proc Natl Acad Sci U S A1997;94:8744-9 PMCID:PMC23107

[279] Wang WH,Hullinger RL.Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-alpha expression..Mol Cell Biol2004;24:10352-65 PMCID:PMC529056

[280] Benhenda S,Buendia MA.Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis..Adv Cancer Res2009;103:75-109

[281] Ng SA.Hepatitis B virus X gene and hepatocarcinogenesis..J Gastroenterol2011;46:974-90

[282] Arzberger S,Protzer U.Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virus..J Virol2010;84:11994-2001 PMCID:PMC2977891

[283] Brenner DA.Signal transduction during liver regeneration..J Gastroenterol Hepatol1998;13:S93-5

[284] FitzGerald MJ,Donovan JR.Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration..Cell Growth Differ1995;6:417-27

[285] Koike K,Yotsuyanagi H,Fujie H,Kimura S.Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis..Cancer Lett1998;134:181-6

[286] Jopling CL,Lancaster AM,Sarnow P.Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA..Science2005;309:1577-81

[287] Henke JI,Zheng J,Schuttler CG,Junemann C.MicroRNA-122 stimulates translation of hepatitis C virus RNA..EMBO J2008;27:3300-10 PMCID:PMC2586803

[288] Kitab B,Ezzikouri S.MicroRNAs as important players in host-hepatitis b virus interactions..J Clin Transl Hepatol2015;3:149-61

[289] Hou J,Zhou W,Ding G,Qin L,Zheng Y,Tian W,Wang C,Zhuang SM,Liang A,Cao X.Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma..Cancer cell2011;19:232-43

[290] Lagos-Quintana M,Yalcin A,Lendeckel W.Identification of tissue-specific microRNAs from mouse..Curr Biol2002;12:735-9

[291] Chen Y,Rider PJ,Wu K,Hao Q,Gong H,Liu F.A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication..FASEB J2011;25:4511-21 PMCID:PMC3236624

[292] Li C,Wang S,Hao J,Ju Y,Chen L,Liu W,Meng S.Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion..J Virol2013;87:2193-205 PMCID:PMC3571498

[293] Qiu L,Jin W,Wang Y,Chen L,Duan Z.MiR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV..Biochem Biophys Res Commun2010;398:771-7

[294] Fornari F,Giovannini C,Ferracin M,Calin GA,Croce CM,Chieco P,Bolondi L.MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells..Cancer Res2009;69:5761-7

[295] Gramantieri L,Fornari F,Sabbioni S,Calin GA,Ferrazzi E,Croce CM,Negrini M.Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma..Cancer Res2007;67:6092-9

[296] Fan CG,Tian C,Li L,Li RF.MiR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3..Oncol Rep2011;26:1281-6

[297] Peng F,Jiang Y,Tian Y,Zhang M,Gong G.HBx down-regulated Gld2 plays a critical role in hbv-related dysregulation of miR-122..PloS One2014;9:e92998

[298] Song K,Zhang J,Dash S,Lim K.Epigenetic regulation of microRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells..Hepatology2013;58:1681-92 PMCID:PMC3773012

[299] Wang S,Yan X,Wang Y,Wu E,Gao GF,Chen Y,Meng S.Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity..Hepatology2012;55:730-41

[300] Denzler R,Stefano J,Stoffel M.Assessing the ceRNA hypothesis with quantitative measurements of mirna and target abundance..Mol Cell2014;54:766-76 PMCID:PMC4267251

[301] Xu G,He W,Feng X,Lu F,Li W.MicroRNA expression in hepatitis B virus infected primary treeshrew hepatocytes and the independence of intracellular miR-122 level for de novo HBV infection in culture..Virology2014;448:247-54

[302] Thornton JE.How does Lin28 let-7 control development and disease?.Trends Cell Biol2012;22:474-82

[303] Guo H,Mitchelson K,Luo M,Sun Y,Lu Y,Ren A,Zhou S,Zhou Y,Wei L,Cheng J.MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B..Hepatology2011;54:808-19

[304] Jin J,Xia L,Xie H,Fan R,Chen Z,Liu J,Fan D.MicroRNA-501 promotes HBV replication by targeting HBXIP..Biochem Biophys Res Commun2013;430:1228-33

[305] Wang Y,Ji X,Zhang Y.Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a/miR-16-1 in hepatocytes..J Biol Chem2013;288:18484-93 PMCID:PMC3689990

[306] Wang Y,Toh ST,Tan P,Chung AY,Lee CG.Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3..J Hepatol2010;53:57-66

[307] Zhang ZZ,Wang DQ,Niu LW,Liang Z.Hepatitis B virus and hepatocellular carcinoma at the miRNA level..World J Gastroenterol2011;17:3353-8 PMCID:PMC3160541

[308] Dai X,Zhang H,Yu H,Kou Z,Du L,Zhang J,Zhou Y.Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1α..Nucleic Acids Res2014;42:6578-90 PMCID:PMC4041434

[309] Gramantieri L,Callegari E,Lanza G,Bolondi L.MicroRNA involvement in hepatocellular carcinoma..J Cell Mol Med2008;12:2189-204 PMCID:PMC4514099

[310] Liu Y,Wang CM,Han P,Cheng YQ,Ma X.Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line..Chin Med J2009;122:10-4

[311] Wu CS,Chou RH,Huang WC,Yu YL.Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression..Int J Cancer2014;134:1638-47

[312] Wu G,Xiao Z,Xu J,Wang J.Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro..Br J Cancer2011;105:146-53 PMCID:PMC3137408

[313] Coppola N,Pisaturo M,Tonziello G,Messina V,Russo A.Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression..PloS One2013;8:e65336

[314] Mosca N,Coppola N,Sagnelli C,Sagnelli E,Potenza N.Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection..Biochem Biophys Res Commun2014;449:141-5

[315] Jung YJ,Park SJ,Jang ES,Jeong SH,Lee SH,Hwang JH,Lee DH.C-Myc-mediated overexpression of miR-17-92 suppresses replication of hepatitis B virus in human hepatoma cells..J Med Virol2013;85:969-78

[316] Cheng PN,Tsai HW,Chang TT.Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents..J Med Virol2011;83:602-7

[317] Ghany MG.Antiviral resistance and hepatitis B therapy..Hepatology2009;49:S174-84

[318] Yang HC.Viral hepatitis. HBV cure--can we pin our hopes on immunotherapy?.Nat Rev Gastroenterol Hepatol2015;12:129-31

[319] Zoulim F.Antiviral therapy of chronic hepatitis B: can we clear the virus and prevent drug resistance?.Antivir Chem Chemother2004;15:299-305

[320] Zoulim F.Emerging drugs for hepatitis B..Expert Opin Emerg Drugs2007;12:199-217 PMCID:PMC3194402